Drug Trial Radar · NCT01220661
Safety and Efficacy of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery
Last checked: Nov 19, 2026Latest source record: Dec 13, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
312
Actual
Start
Oct 2010
Primary completion
Dec 2011
Study completion Dec 2011
Sponsor
- Lead sponsor
- National Cancer Center, KoreaGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Oct 14, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In colorectal surgery, the use of prophylactic antibiotics is recommended. The standard use of antibiotics for colorectal surgery is three doses. It has been reported that the surgical site infection rates of laparoscopic colorectal surgery are lower than open colorectal surgery. However, the evidence of proper application of antibiotic for laparoscopic colorectal surgery is still not enough. The investigators are researching the efficacy and safety of one dose prophylactic antibiotic in laparoscopic colorectal surgery.
Conditions
- Colorectal Surgery
Interventions
CefotetanDrug
preoperative one dose prophylactic antibiotic (2g iv, within 1 hour before skin incision)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical site infectionTime frame: Three weeks after surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Cancer Center Hospital
Goyang-si, Gyeonggi-do, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.